Molecularly imprinted polymer nanocarriers for sustained release of erythromycin

Pharmaceutical Research

Volumn 32, Issue 2, 2015, Pages 375-388

  Kempe, Henrik ^a   Pujolràs, Anna Parareda ^a   Kempe, Maria ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Antibiotics; Drug delivery; Molecular imprinting; Nanoparticles; Sustained release

Indexed keywords

DELAYED RELEASE FORMULATION; ERYTHROMYCIN; NANOCAPSULE; POLYMER;

CHEMISTRY; DELAYED RELEASE FORMULATION; METABOLISM; MOLECULAR IMPRINTING; PARTICLE SIZE; PROCEDURES;

DELAYED-ACTION PREPARATIONS; ERYTHROMYCIN; MOLECULAR IMPRINTING; NANOCAPSULES; PARTICLE SIZE; POLYMERS;

EID: 84939895847     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-014-1468-2     Document Type: Article

References (39)

1. Xu Z-Q, Flavin MT, Eiznhamer DA. Macrolides and ketolides. In: Dougherty TJ, Pucci MJ, editors. Antibiotic Discovery and Development. New York: Springer; 2012. p. 181-228.
2. Kanoh S, Rubin BK. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev. 2010;23(3):590-615.
3. Fumimori T, Honda S, Migita K, Hamada M, Yoshimuta T, Honda J, et al. Erythromycin suppresses the expression of cyclooxygenase-2 in rheumatoid synovial cells. J Rheumatol. 2004;31(3):436-41.
4. Ren W, Blasier R, Peng X, Shi T, Wooley PH, Markel D. Effect of oral erythromycin therapy in patients with aseptic loosening of joint prostheses. Bone. 2009;44(4):671-7.
5. Suzuki J, Ogawa M, Hishikari K, Watanabe R, Takayama K, Hirata Y, et al. Novel effects of macrolide antibiotics on cardiovascular diseases. Cardiovasc Ther. 2012;30(6):301-7.
6. Shinkai M, Henke MO, Rubin BK. Macrolide antibiotics as immunomodulatory medications: Proposed mechanisms of action. Pharmacol Ther. 2008;117(3):393-405.
7. Augustine JJ, Bodziak KA, Hricik DE. Use of sirolimus in solid organ transplantation. Drugs. 2007;67(3):369-91.
8. Ruygrok PN, Muller DW, Serruys PW. Rapamycin in cardiovascular medicine. Int Med J. 2003;33(3):103-9.
9. Bosnjakovic A, Mishra MK, Ren W, Kurtoglu YE, Shi T, Fan D, et al. Poly (amidoamine) dendrimer-erythromycin conjugates for drug delivery to macrophages involved in periprosthetic inflammation. Nanomedicine. 2011;7(3):284-94.
10. Doadrio JC, Sousa EMB, Izquierdo-Barb I, Doadrio AL, Perez-Pariente J, Vallet-Regí M. Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern. J Mater Chem. 2006;16(5):462-6.
11. Portilla-Arias JA, Camargo B, García-Alvarez M, de Ilarduya AM, Muñoz-Guerra S. Nanoparticles made of microbial poly(γ-glutamate)s for encapsulation and delivery of drugs and proteins. J Biomat Sci. 2009;20(7-8):1065-79.
12. Alexander C, Andersson HS, Andersson LI, Ansell RJ, Kirsch N, Nicholls IA, et al. Molecular imprinting science and technology: a survey of the literature for the years up to and including 2003. J Mol Recognit. 2006;19(2):106-80.
13. Kempe H, Kempe M. Molecularly imprinted polymers. In: Albericio F, Tulla-Puche J, editors. The Power of Functional Resins in Organic Synthesis. Weinheim: Wiley; 2008. p. 15-44.
14. Alvarez-Lorenzo C, Concheiro A. Molecularly imprinted materials as advanced excipients for drug delivery systems. Biotechnol Annu Rev. 2006;12:225-68.
15. Kryscio DR, Peppas NA. Mimicking biological delivery through feedback-controlled drug release systems based on molecular imprinting. AIChE J. 2009;55(6):1311-24.
16. Fernández-González A, Guardia L, Badía-Laíño R, Díaz-García ME. Mimicking molecular receptors for antibiotics - analytical implications. Trends Anal Chem. 2006;25(10):949-57.
17. Cederfur J, Pei Y, Zihui M, Kempe M. Synthesis and screening of a molecularly imprinted polymer library targeted for penicillin G. J Comb Chem. 2003;5(1):67-72.
18. Benito-Pena E, Moreno-Bondi MC, Aparicio S, Orellana G, Cederfur J, Kempe M. Molecular engineering of fluorescent penicillins for molecularly imprinted polymer assays. Anal Chem. 2006;78(6):2019-27.
19. Kempe H, Kempe M. Influence of salt ions on binding to molecularly imprinted polymers. Anal Bioanal Chem. 2010;396(4):1599-606.
20. Kempe H, Kempe M. QSRR analysis of β-lactam antibiotics on a penicillin G targeted MIP stationary phase. Anal Bioanal Chem. 2010;398(7-8):3087-96.
21. Levi R, McNiven S, Piletsky SA, Cheong S-H, Yano K, Karube I. Optical detection of chloramphenicol using molecularly imprinted polymers. Anal Chem. 1997;69(11):2017-21.
22. Mirzaei M, Najafabadi SAH, Abdouss M, Azodi-Deilami S, Asadi E, Hosseini MRM, et al. Preparation and utilization of microporous molecularly imprinted polymer for sustained release of tetracycline. J Appl Poly Sci. 2013;128(3):1557-62.
23. Shi Y, Lv H, Lu X, Huang Y, Zhang Y, Xue W. Uniform molecularly imprinted poly (methacrylic acid) nanospheres prepared by precipitation polymerization: the control of particle features suitable for sustained release of gatifloxacin. J Mater Chem. 2012;22(9):3889-98.
24. Siemann M, Andersson LI, Mosbach K. Separation and detection of macrolide antibiotics by HPLC using macrolide-imprinted synthetic polymers as stationary phases. J Antibiot. 1997;50(1):89-95.
25. Song S, Wu A, Shi X, Li R, Lin Z, Zhang D. Development and application of molecularly imprinted polymers as solid-phase sorbents for erythromycin extraction. Anal Bioanal Chem. 2008;390(8):2141-50.
26. Geng L, Kou X, Lei J, Su H, Maa G, Su Z. Preparation, characterization and adsorption performance of molecularly imprinted microspheres for erythromycin using suspension polymerization. J Chem Technol Biotechnol. 2012;87(5):635-42.
27. Kou X, Lei J, Geng L, Deng H, Jiang Q, Zhang G, et al. Synthesis, characterization and adsorption behavior of molecularly imprinted nanospheres for erythromycin using precipitation polymerization. J Nanosci Nanotechnol. 2012;12(9):7388-94.
28. Zhang Z, Yang X, Zhang H, Zhang M, Luo L, Hu Y, et al. Novel molecularly imprinted polymers based on multi-walled carbon nanotubes with binary functional monomer for the solid-phase extraction of erythromycin from chicken muscle. J Chromatogr B. 2011;879(19):1617-24.
29. Kempe M, Mosbach K. Receptor binding mimetics: a novel molecularly imprinted polymer. Tetrahedron Lett. 1995;36(20):3563-6.
30. Kempe M. Antibody mimicking polymers as chiral stationary phases in HPLC. Anal Chem. 1996;68(11):1948-53.
31. Ye L, Cormack PAG, Mosbach K. Molecularly imprinted monodisperse microspheres for competitive radioassay. Anal Commun. 1999;36(2):35-8.
32. Connolly ML. Computation of molecular volume. J Am Chem Soc. 1985;107(5):1118-24.
33. Sibrian-Vazquez M, Spivak DA. Molecular imprinting made easy. J Am Chem Soc. 2004;126(25):7827-33.
34. Ray RS, Mehrotra S, Shankar U, Suresh Babu G, Joshi PC, Hans RK. Evaluation of UV-induced superoxide radical generation potential of some common antibiotics. Drug Chem Toxicol. 2001;24(2):191-200.
35. Jedliński Z, Paprotny J. Synthesis and polymerisation of some N-alkylolacryl-amides. III. Polymerization of 2-methacrylamido-2-methyl-propanediol-l,3 and 2-methacrylamido-2-methylpropanol-1. J Polym Sci Part A-1. 1967;5(11):2957-60.
36. Karlsson JG, Karlsson B, Andersson LI, Nicholls IA. The roles of template complexation and ligand binding conditions on recognition in bupivacaine molecularly imprinted polymers. Analyst. 2004;129(5):456-62.
37. Zhang Y, Song D, Lanni LM, Shimizu KD. Importance of functional monomer dimerization in the molecular imprinting process. Macromolecules. 2010;43(15):6284-94.
38. Cacho C, Turiel E, Martin-Esteban A, Pérez-Conde C, Cámara C. Characterisation and quality assessment of binding sites on a propazine-imprinted polymer prepared by precipitation polymerization. J Chromatogr B. 2004;802(2):347-53.
39. Chen Z, Ye L. Controlling size and uniformity of molecularly imprinted nanoparticles using auxiliary template. J Mol Recognit. 2012;25(6):370-6.